In the larger TCGA-GBM Agilent 4502A dataset, we found expression of SLC2A14 is inversely proportional to patient survival, p < 0.05, and SLC2A3 and SLC2A14 expression is highly correlated (Supplemental Figure S2A) [27,28,29]. The gene discussed is SLC2A3; the disease is glioblastoma.